Cardinal Health Inc (CAH) stock
CAHNYSEWholesale-Drugs, Proprietaries & Druggists' SundriesFiscal year ends June 30
Financials through Q1 FY2027, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 16/3037% above fair value
$281.10+2.96 (+1.06%)
Close on Nov 13, 2026Market cap $65.38BP/E 36.3Yield 0.73%
Cardinal Health ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
Cardinal Health's ebitda for the twelve months ending Sep 30, 2026 was $3.67B, up 14.1% year over year. For fiscal 2026 it was $3.57B, up 16.4% from the year before. Over ten years it grew 1.4% a year on average. The highest annual figure on record is $3.57B in fiscal 2026.
Annual ebitda
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Jun 30, 2026 | $3.57B | +16.4% |
| FY2025 | Jun 30, 2025 | $3.07B | +56.9% |
| FY2024 | Jun 30, 2024 | $1.95B | +35.2% |
| FY2023 | Jun 30, 2023 | $1.44B | +1598.8% |
| FY2022 | Jun 30, 2022 | $85.00M | -93.2% |
| FY2021 | Jun 30, 2021 | $1.26B | – |
| FY2020 | Jun 30, 2020 | -$3.19B | -204.1% |
| FY2019 | Jun 30, 2019 | $3.06B | +164.2% |
| FY2018 | Jun 30, 2018 | $1.16B | -59.2% |
| FY2017 | Jun 30, 2017 | $2.84B | -8.5% |
| FY2016 | Jun 30, 2016 | $3.10B | +18.7% |
| FY2015 | Jun 30, 2015 | $2.61B | +11.4% |
| FY2014 | Jun 30, 2014 | $2.34B | +68.3% |
| FY2013 | Jun 30, 2013 | $1.39B | -34.2% |
| FY2012 | Jun 30, 2012 | $2.12B | +15.9% |
| FY2011 | Jun 30, 2011 | $1.83B | +17.0% |
| FY2010 | Jun 30, 2010 | $1.56B | +3.2% |
| FY2009 | Jun 30, 2009 | $1.51B | -6.2% |
| FY2008 | Jun 30, 2008 | $1.61B | – |
Quarterly ebitda
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q1 FY2027CQ3 2026 | Sep 30, 2026 | $1.00B | +11.0% |
| Q4 FY2026CQ2 2026 | Jun 30, 2026 | $970.00M | +52.3% |
| Q3 FY2026CQ1 2026 | Mar 31, 2026 | $757.00M | -19.2% |
| Q2 FY2026CQ4 2025 | Dec 31, 2025 | $941.00M | +27.0% |
| Q1 FY2026CQ3 2025 | Sep 30, 2025 | $901.00M | +20.1% |
| Q4 FY2025CQ2 2025 | Jun 30, 2025 | $637.00M | +8.5% |
| Q3 FY2025CQ1 2025 | Mar 31, 2025 | $937.00M | +71.6% |
| Q2 FY2025CQ4 2024 | Dec 31, 2024 | $741.00M | +9.0% |
| Q1 FY2025CQ3 2024 | Sep 30, 2024 | $750.00M | +435.7% |
| Q4 FY2024CQ2 2024 | Jun 30, 2024 | $587.00M | +73.7% |
| Q3 FY2024CQ1 2024 | Mar 31, 2024 | $546.00M | -29.9% |
| Q2 FY2024CQ4 2023 | Dec 31, 2023 | $680.00M | +709.5% |
| Q1 FY2024CQ3 2023 | Sep 30, 2023 | $140.00M | -52.4% |
| Q4 FY2023CQ2 2023 | Jun 30, 2023 | $338.00M | +65.7% |
| Q3 FY2023CQ1 2023 | Mar 31, 2023 | $779.00M | +827.4% |
| Q2 FY2023CQ4 2022 | Dec 31, 2022 | $84.00M | – |
| Q1 FY2023CQ3 2022 | Sep 30, 2022 | $294.00M | -49.6% |
| Q4 FY2022CQ2 2022 | Jun 30, 2022 | $204.00M | -40.4% |
| Q3 FY2022CQ1 2022 | Mar 31, 2022 | $84.00M | -87.5% |
| Q2 FY2022CQ4 2021 | Dec 31, 2021 | -$786.00M | -219.1% |
| Q1 FY2022CQ3 2021 | Sep 30, 2021 | $583.00M | – |
| Q4 FY2021CQ2 2021 | Jun 30, 2021 | $342.00M | -30.9% |
| Q3 FY2021CQ1 2021 | Mar 31, 2021 | $672.00M | -14.5% |
| Q2 FY2021CQ4 2020 | Dec 31, 2020 | $660.00M | +17.0% |
| Q1 FY2021CQ3 2020 | Sep 30, 2020 | -$419.00M | – |
| Q4 FY2020CQ2 2020 | Jun 30, 2020 | $495.00M | -9.8% |
| Q3 FY2020CQ1 2020 | Mar 31, 2020 | $786.00M | +13.4% |
| Q2 FY2020CQ4 2019 | Dec 31, 2019 | $564.00M | -25.5% |
| Q1 FY2020CQ3 2019 | Sep 30, 2019 | -$5.03B | -574.1% |
| Q4 FY2019CQ2 2019 | Jun 30, 2019 | $549.00M | – |
| Q3 FY2019CQ1 2019 | Mar 31, 2019 | $693.00M | -13.9% |
| Q2 FY2019CQ4 2018 | Dec 31, 2018 | $757.00M | +9.7% |
| Q1 FY2019CQ3 2018 | Sep 30, 2018 | $1.06B | +116.1% |
| Q4 FY2018CQ2 2018 | Jun 30, 2018 | -$827.00M | -231.1% |
| Q3 FY2018CQ1 2018 | Mar 31, 2018 | $805.00M | +1.8% |
| Q2 FY2018CQ4 2017 | Dec 31, 2017 | $690.00M | -2.5% |
| Q1 FY2018CQ3 2017 | Sep 30, 2017 | $491.00M | – |
| Q4 FY2017CQ2 2017 | Jun 30, 2017 | $631.00M | – |
| Q3 FY2017CQ1 2017 | Mar 31, 2017 | $791.00M | – |
| Q2 FY2017CQ4 2016 | Dec 31, 2016 | $708.00M | – |
See a number that looks wrong?